A Decade after Foetal Skin Progenitor Cell Therapy in Pediatric Burn Treatment

Abstract

A decade ago, a study was reported on the management of pediatric burns using cell therapy and foetal skin progenitor cells. We now present follow-up on the patients in that original clinical study. We describe the regulatory requirements for clinical research, specifically that research conducted in a hospital environment and involving human cell and tissue based products. Also, how these requirements have changed since 2007 and how these changes might adversely affect burn victims and their Clinical Care Pathways in the future will be addressed in this report.